Professor Junbo Ge, M.D. is a cardiologist passionate about improving care pathways in cardiovascular health. He has worked to improve coronary artery disease (CAD) diagnosis and treatment through innovation, making extraordinary advancements in intravascular ultrasound (IVUS). His research areas include novel coronary stents, treatment strategy optimization for complex cases of CAD, and stem cell therapy. He developed China’s first biodegradable, drug-coated coronary stent in 2005 and is the first physician in China to successfully complete a percutaneous aortic valve replacement, percutaneous mitral valve repair, and percutaneous pulmonary arterioplasty. He is currently serving as president of the Chinese Society of Cardiology, chairman of the China Cardiovascular Association, head of the cardiology department at Zhongshan Hospital at Fudan University, trustee member of The Society for Cardiovascular Angiography and Interventions, member of the international advisory board of American College of Cardiology, and member of the Chinese Academy of Sciences. He is also head of the Shanghai Cardiovascular Clinical Center, chairman of the Shanghai Institute of Cardiovascular Diseases, head of the Institute of Biomedical Sciences, head of the Institute for Panvascular Medical Research at Fudan University, chairman of the Panvascular Fund at Fudan University, and director of the Engineering Research Center for Cardiovascular Devices at the Ministry of Education. Prof. Ge has been responsible for over 20 scientific research projects supported by the Chinese government. He has published over 300 papers in internationally-recognized journals, edited 20 books (one published abroad), and co-edited more than 20 monographs and textbooks.